Abstract Background Glioblastoma (GBM) is the most common brain tumor with the worst prognosis. Temozolomide is the only first-line drug for GBM. Unfortunately. the resistance issue is a classic problem. https://www.foldlyers.shop/product-category/toaster-and-kettle-sets/